Experienced in Diabetic Hyperglycemic Hyperosmolar Syndrome

Shane W. English

Ottawa, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Diabetic Hyperglycemic Hyperosmolar Syndrome
Ottawa, ON, CA 
OverviewLocationsClinical Research

Overview

Shane English practices in Ottawa, Canada. Mr. English is rated as an Experienced expert by MediFind in the treatment of Diabetic Hyperglycemic Hyperosmolar Syndrome. His top areas of expertise are Subarachnoid Hemorrhage, Gastrointestinal Bleeding, Peptic Ulcer, Severe Acute Respiratory Syndrome (SARS), and Kidney Transplant.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Diabetic Hyperglycemic Hyperosmolar Syndrome.

Gender
Male

Locations

Ottawa, ON, Canada
Other Locations
Quebec, St. Joseph's Healthcare Hamilton Research Institute, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Dalteparin
Study Phase: Phase 3
Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial
Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: UC-MSCs
Study Phase: Phase 2
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)-Pilot Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
A Randomized, Double-blind, Placebo-controlled, Study Evaluating the Efficacy and Safety of Otilimab IV in Patients With Severe Pulmonary COVID-19 Related Disease
Enrollment Status: Completed
Publish Date: September 23, 2024
Intervention Type: Biological, Drug
Study Drugs: Otilimab, Standard of Care
Study Phase: Phase 2
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) Trial
Enrollment Status: Completed
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: Pantoprazole
Study Phase: Phase 3
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO: Canadian Treatments for COVID-19), in Conjunction With the Public Health Emergency SOLIDARITY Trial (World Health Organization)
Enrollment Status: Unknown
Publish Date: October 13, 2023
Intervention Type: Drug
Study Drugs: IFN-Beta1a, Remdesivir
Study Phase: Phase 3
Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)
Cellular Immuno-Therapy for COVID-19 ARDS (CIRCA-19)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

125 Total Publications

Cost-Effectiveness of In-Bed Cycling and Routine Physiotherapy for Patients Receiving Mechanical Ventilation.
Cost-Effectiveness of In-Bed Cycling and Routine Physiotherapy for Patients Receiving Mechanical Ventilation.
Journal: JAMA network open
Published: September 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. English's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile